Apellis Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
All right. We'll go ahead and get started. So welcome to the Tuesday afternoon session of the 2020 JPMorgan Healthcare Conference. My name is Anupam Rama. I am joined by Matt Bannon, Tessa Romero and Julie Murphy from the team. Our next presenting company is Apellis, and presenting on behalf of the company is Cedric Francois. Cedric?
Thank you very much, Anupam, and thank you for inviting us for the third year in a row, and all the hard work that you and the team do for us. And thank you all of you for attending. This is a special JPMorgan for us where we are presenting to you the data from our PEGASUS study in paroxysmal nocturnal hemoglobinuria. And we are going to start with this slide, where of course, today, a lot of time will be spent on those positive data in our Phase III clinical trial, but also on the platform that we believe we are unlocking around this fascinating target of complement
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |